Martin Buckland

Martin Buckland

Chief Executive Officer at Astex Pharmaceuticals, Inc.

69 year
Health Technology
Consumer Services
Commercial Services

Profile

Martin Buckland is currently the Chief Executive Officer at Astex Pharmaceuticals, Inc. and a Member at The Royal Institution of Chartered Surveyors.
Previously, he held positions such as Director-Sales & Marketing at ADAS Consulting Ltd., Chief Business Officer & Director at Astex Therapeutics Ltd., Vice President at Xenova Group Plc, Chief Business Officer at SuperGen, Inc., Principal at Celltech Group Plc, Vice President-Periclinical Services at Quintiles, Inc. (California), and Vice President-Global Business Development at Elan Pharmaceuticals, LLC.
Dr. Buckland obtained his undergraduate and doctorate degrees from the University of Oxford and holds an MBA from The Open University and The Open University Business School.

Martin Buckland active positions

CompaniesPositionStart
Corporate Officer/Principal 2010-11-08
Chief Executive Officer 2011-06-30
All active positions of Martin Buckland

Former positions of Martin Buckland

CompaniesPositionEnd
Corporate Officer/Principal 2011-09-12
Sales & Marketing -
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
See the detail of Martin Buckland's experience

Training of Martin Buckland

University of Oxford Doctorate Degree
The Open University Masters Business Admin
The Open University Business School Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Martin Buckland's experience

Connections

100 +

1st degree connections

12

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies9

Health Technology

Health Technology

Health Services

Commercial Services

Health Technology

Process Industries

Commercial Services

Health Technology

Health Technology

See company connections
  1. Stock Market
  2. Insiders
  3. Martin Buckland
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW